Publications

Detailed Information

Receptor tyrosine and MAP kinase are involved in effects of H(2)O(2) on interstitial cells of Cajal in murine intestine

DC Field Value Language
dc.contributor.authorChoi, Seok-
dc.contributor.authorYeum, Cheol Ho-
dc.contributor.authorKim, Young Dae-
dc.contributor.authorPark, Jong-Seong-
dc.contributor.authorJeong, Han-Seong-
dc.contributor.authorKim, Man Yoo-
dc.contributor.authorPark, Chan Guk-
dc.contributor.authorKim, Byung Joo-
dc.contributor.authorKim, Ki Whan-
dc.contributor.authorJun, Jae Yeoul-
dc.contributor.authorSo, Insuk-
dc.date.accessioned2012-05-22T06:29:18Z-
dc.date.available2012-05-22T06:29:18Z-
dc.date.issued2010-02-
dc.identifier.citationJOURNAL OF CELLULAR AND MOLECULAR MEDICINE; Vol.14, No 1-2; 257-266ko_KR
dc.identifier.issn1582-1838-
dc.identifier.urihttps://hdl.handle.net/10371/76239-
dc.description.abstractHydrogen peroxide (H(2)O(2)) is involved in intestinal motility through changes of smooth muscle activity. However, there is no report as to the modulatory effects of H(2)O(2) on interstitial cells of Cajal (ICC). We investigated the H(2)O(2) effects and signal transductions to determine whether the intestinal motility can be modulated through ICC. We performed whole-cell patch clamp in cultured ICC from murine intestine and molecular analyses. H(2)O(2) hyperpolarized the membrane and inhibited pacemaker currents. These effects were inhibited by glibenclamide, an inhibitor of ATP-sensitive K+ (K(ATP)) channels. The free-radical scavenger catalase inhibited the H(2)O(2)-induced effects. MAFP and AACOCF(3) (a cytosolic phospholipase A(2) inhibitors) or SC-560 and NS-398 (a selective COX-1 and 2 inhibitor) or AH6809 (an EP(2) receptor antagonist) inhibited the H(2)O(2)-induced effects. PD98059 (a mitogen activated/ERK-activating protein kinase inhibitor) inhibited the H(2)O(2)-induced effects, though SB-203580 (a p38 MAPK inhibitor) or a JNK inhibitor did not affect. H(2)O(2)-induced effects could not be inhibited by LY-294002 (an inhibitor of PI(3)-kinases), calphostin C (a protein kinase C inhibitor) or SQ-22536 (an adenylate cyclase inhibitor). Adenoviral infection analysis revealed H(2)O(2) stimulated tyrosine kinase activity and AG 1478 (an antagonist of epidermal growth factor receptor tyrosine kinase) inhibited the H(2)O(2)-induced effects. These results suggest H(2)O(2) can modulate ICC pacemaker activity and this occur by the activation of K(ATP) channels through PGE(2) production via receptor tyrosine kinase-dependent MAP kinase activation.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-BLACKWELL PUBLISHING, INCko_KR
dc.subjecthydrogen peroxideko_KR
dc.subjectpacemaker currentsko_KR
dc.subjectcyclooxygenaseko_KR
dc.subjectMAP kinaseko_KR
dc.subjectreceptor tyrosine kinaseko_KR
dc.subjectinterstitial cells of Cajalko_KR
dc.titleReceptor tyrosine and MAP kinase are involved in effects of H(2)O(2) on interstitial cells of Cajal in murine intestineko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor최석-
dc.contributor.AlternativeAuthor전재열-
dc.contributor.AlternativeAuthor김기완-
dc.contributor.AlternativeAuthor소인석-
dc.contributor.AlternativeAuthor박찬국-
dc.contributor.AlternativeAuthor김만유-
dc.contributor.AlternativeAuthor박종성-
dc.contributor.AlternativeAuthor김병주-
dc.contributor.AlternativeAuthor정한성-
dc.contributor.AlternativeAuthor김영대-
dc.contributor.AlternativeAuthor염철호-
dc.identifier.doi10.1111/j.1582-4934.2008.00403.x-
dc.citation.journaltitleJOURNAL OF CELLULAR AND MOLECULAR MEDICINE-
dc.description.citedreferenceSong HJ, 2005, J PHARMACOL EXP THER, V312, P391, DOI 10.1124/jpet.104.074401-
dc.description.citedreferenceShimojima N, 2005, PHARMACOLOGY, V74, P95, DOI 10.1159/000084021-
dc.description.citedreferenceCao WB, 2004, J PHARMACOL EXP THER, V311, P60, DOI 10.1124/jpet.104.068023-
dc.description.citedreferenceLin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101-
dc.description.citedreferenceWard SM, 2004, NEUROGASTROENT MOTIL, V16, P112-
dc.description.citedreferencePrasad M, 2004, AM J PHYSIOL-CELL PH, V286, pC671, DOI 10.1152/ajpcell.00137.2003-
dc.description.citedreferenceJun JY, 2004, BRIT J PHARMACOL, V141, P670, DOI 10.1038/sj.bjp.0705665-
dc.description.citedreferenceJabbour HN, 2003, J CLIN ENDOCR METAB, V88, P4481, DOI 10.1210/jc.2003-030297-
dc.description.citedreferenceCao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002-
dc.description.citedreferencePolosukhina D, 2003, AM J NEPHROL, V23, P380, DOI 10.1159/000073984-
dc.description.citedreferenceStork PJS, 2002, TRENDS CELL BIOL, V12, P258-
dc.description.citedreferenceVrees MD, 2002, ARCH SURG-CHICAGO, V137, P439-
dc.description.citedreferencePai R, 2002, NAT MED, V8, P289-
dc.description.citedreferenceXiao ZL, 2002, AM J PHYSIOL-GASTR L, V282, pG300-
dc.description.citedreferencePearson G, 2001, ENDOCR REV, V22, P153-
dc.description.citedreferenceYang ZW, 1999, N-S ARCH PHARMACOL, V360, P646-
dc.description.citedreferenceNarumiya S, 1999, PHYSIOL REV, V79, P1193-
dc.description.citedreferenceTabet F, 2005, J HYPERTENS, V23, P2005-
dc.description.citedreferenceCheng L, 2005, GASTROENTEROLOGY, V129, P1675, DOI 10.1053/j.gastro.2005.09.008-
dc.description.citedreferenceCao W, 2005, AM J PHYSIOL-CELL PH, V289, pC1408, DOI 10.1152/ajpcell.00073.2005-
dc.description.citedreferenceFaussone-Pellegrini MS, 2006, J CELL MOL MED, V10, P20-
dc.description.citedreferenceChoi S, 2006, CELL PHYSIOL BIOCHEM, V18, P187-
dc.description.citedreferenceChoi S, 2006, LIFE SCI, V78, P2322, DOI 10.1016/j.lfs.2005.09.032-
dc.description.citedreferencePopescu LM, 2006, EUR J PHARMACOL, V546, P177, DOI 10.1016/j.ejphar.2006.06.068-
dc.description.citedreferenceYin JY, 2006, DIGEST DIS SCI, V51, P1818, DOI 10.1007/s10620-006-9313-z-
dc.description.citedreferenceCao WB, 2006, AM J PHYSIOL-GASTR L, V291, pG672, DOI 10.1152/ajpgi.00110.2006-
dc.description.citedreferenceOZAKI H, 2005, INFLAMMOPHARMACOLOGY, V13, P103-
dc.description.citedreferenceJun JY, 2005, BRIT J PHARMACOL, V144, P242, DOI 10.1038/sj.bjp.0706074-
dc.description.citedreferenceDaniel EE, 2005, NEUROGASTROENT MOTIL, V17, P355, DOI 10.1111/j.1365-2982.2005.00639.x-
dc.description.citedreferenceKataoka K, 2005, J GASTROENTEROL, V40, P610, DOI 10.1007/s00535-005-1595-y-
dc.description.citedreferenceLuttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177-
dc.description.citedreferenceHackel PO, 1999, CURR OPIN CELL BIOL, V11, P184-
dc.description.citedreferenceLu G, 1999, GASTROENTEROLOGY, V116, P884-
dc.description.citedreferenceKoh SD, 1998, J PHYSIOL-LONDON, V513, P203-
dc.description.citedreferenceZhang JH, 1998, AM J RESP CELL MOL, V19, P324-
dc.description.citedreferenceThomsen L, 1998, NAT MED, V4, P848-
dc.description.citedreferenceSanders KM, 1998, AM J PHYSIOL-GASTR L, V275, pG1-
dc.description.citedreferenceAbe MK, 1998, AM J RESP CELL MOL, V18, P562-
dc.description.citedreferenceLu G, 1997, AM J PHYSIOL-GASTR L, V273, pG1233-
dc.description.citedreferenceMyers BS, 1997, AM J PHYSIOL-GASTR L, V273, pG928-
dc.description.citedreferenceHawes BE, 1996, J BIOL CHEM, V271, P12133-
dc.description.citedreferenceGOLDHILL JM, 1995, AM J PHYSIOL-GASTR L, V268, pG823-
dc.description.citedreferenceHUIZINGA JD, 1995, NATURE, V373, P347-
dc.description.citedreferenceCROSS DAE, 1994, BIOCHEM J, V303, P21-
dc.description.citedreferenceWARD SM, 1994, J PHYSIOL-LONDON, V480, P91-
dc.description.citedreferenceGRISHAM MB, 1994, LANCET, V344, P859-
dc.description.citedreferenceZHANG L, 1994, AM J PHYSIOL, V267, pG494-
dc.description.citedreferenceBLENNERHASSETT MG, 1992, AM J PHYSIOL, V262, pG1041-
dc.description.citedreferenceREDDY SN, 1991, GASTROENTEROLOGY, V101, P1289-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share